Tsai Hsin-Chung, Lehman Caitlin W, Lin Chi-Chieh, Tsai Sen-Wei, Chen Chuan-Mu
Department of Surgery, Taichung Hospital, Ministry of Health and Welfare, 199 San Min Rd., Sec. 1, Taichung, Taiwan.
Department of Life Sciences, The iEGG and Animal Biotechnology Center, National Chung Hsing University, 145 Xinda Rd., Taichung, 402, Taiwan.
BMC Res Notes. 2019 Feb 26;12(1):101. doi: 10.1186/s13104-019-4134-2.
Influenza is an acute respiratory disease caused by the influenza virus which circulates annually in populations of different species. Madin-Darby Canine Kidney (MDCK) is the most widely utilized cell-line for conducting influenza research. However, the infectivity of various influenza strains in MDCK cells is not equivalent and the productivity of viral propagation is also limited.
We tested the functional adequacy of two MDCK-lineage cell lines, conventional MDCK and MDCK/London, were evaluated by assessing their infectivity of different influenza viral strains with focus forming assays and the cellular toxicity caused by influenza infections by lactate dehydrogenase assay. Moreover, the sensitivity of cells in the presence of the antiviral agent ribavirin was assessed by MTT assay. Our results showed that MDCK/London cells efficiently propagate virus across all influenza viruses tested, are comparable to the utility of Mv1Lu cells, and are superior to conventional MDCK cells in replicating virus as indicated by an increase in virus of three to four logs, particularly in H3N2 infection. Also, the MDCK/London cells were more sensitive to the presence of antiviral drug than conventional MDCK cells. In conclusion, MDCK/London cell line could be a better platform for influenza studies and vaccine development.
流感是一种由流感病毒引起的急性呼吸道疾病,该病毒每年在不同物种群体中传播。犬肾传代细胞(MDCK)是进行流感研究最广泛使用的细胞系。然而,各种流感毒株在MDCK细胞中的感染性并不相同,病毒增殖的产量也有限。
我们通过空斑形成试验评估了两种MDCK谱系细胞系(传统MDCK和MDCK/伦敦)对不同流感病毒株的感染性,并通过乳酸脱氢酶试验评估了流感感染引起的细胞毒性,以此测试了它们的功能适用性。此外,通过MTT试验评估了细胞在抗病毒药物利巴韦林存在下的敏感性。我们的结果表明,MDCK/伦敦细胞能有效地在所有测试的流感病毒中传播病毒,与Mv1Lu细胞的效用相当,并且在复制病毒方面优于传统MDCK细胞,病毒增加了三到四个对数,特别是在H3N2感染中。此外,MDCK/伦敦细胞对抗病毒药物的存在比传统MDCK细胞更敏感。总之,MDCK/伦敦细胞系可能是流感研究和疫苗开发的更好平台。